Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Solentim Ltd
Solentim Ltd
Activities:
Analysis
Pharmaceutical
X
LinkedIn
Trending Articles
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride
The two companies aim to expand the distribution of benzalkonium chloride within Europe
Upperton opens novel development and GMP manufacturing facility
The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development...
Astellas begins construction of manufacturing site in Tralee
600 construction jobs and 100 specialised engineering, science and technology roles will be created from the project
Policy vacuum risks UK becoming a medicines supply backwater
The UK becoming a "backwater" supply marker could jeopardise £18bn of NHS savings from newly off-patented drugs during the next five years
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Finance
Cell-based therapy specialist Solentim expands European operations
The England-based company has established a new EU entity based in Ireland to facilitate frictionless business within the EU
Finance
Solentim expands operations to China
“This direct investment will help us support and expand our activities,” said General Manager of Solentim China, Kun Peng
Research & Development
Solentim launches workflow for single stem cell cloning
The company aims to create, isolate and characterise the highest value cells for biological medicine development
Manufacturing
Solentim names new Chief Marketing Officer
Dr Mark Truesdale will join the cell line development (CLD) instrumentation specialist
Pharmaceutical
Solentim and SAL Scientific partner on cell line development
Collaboration will add SAL’s new growth supplements for cell culture media to Solentim's offerings
Finance
Research funding round-up
Capital to support the development of new drugs and technology around the world
Manufacturing
Simple, single-use TFF solution for R&D or manufacturing
Solentim claims significant time-saving advantages are provided by its new systems
Subscribe now